Professional Documents
Culture Documents
1680163559744-Acute Respiratory F
1680163559744-Acute Respiratory F
Classification of RF
Diagnosis of RF
Causes
Clinical presentation
Investigations
Management of RF
1
11/2/2021
Hypoxemia
Hypercapnia.
Fig. 68-1
2
11/2/2021
3
11/2/2021
4
11/2/2021
Fig. 68-2
5
11/2/2021
Asthma
Atelectasis
Pulmonary embolus
6
11/2/2021
7
11/2/2021
Shunt
Anatomic shunt
Intrapulmonary shunt
8
11/2/2021
Diffusion limitation
Severe emphysema
Pulmonary fibrosis
9
11/2/2021
Diffusion Limitation
Fig. 68-5
CNS disease
Neuromuscular disease
Interrelationship of mechanisms
Combination of two or more physiologic mechanisms
10
11/2/2021
Emphysema
Chronic bronchitis
Cystic fibrosis
Drug overdose
Brainstem infarction
11
11/2/2021
Chest wall
Flail chest
Fractures
Mechanical restriction
Muscle spasm
Neuromuscular conditions
Muscular dystrophy
Multiple sclerosis
12
11/2/2021
Respiratory Failure
Tissue Organ Needs
Major threat is the inability of the lungs to meet the
oxygen demands of the tissues
13
11/2/2021
Respiratory Failure
Clinical Manifestations
Sudden or gradual onset
Respiratory Failure
Clinical Manifestations
Severe morning headache
Early signs
Cyanosis
Late sign
14
11/2/2021
15
11/2/2021
16
11/2/2021
Diagnostic Studies
History and physical assessment
ABG analysis
Chest x-ray
CBC, sputum/blood cultures, electrolytes
ECG
Urinalysis
V/Q lung scan
Pulmonary artery catheter (severe cases)
Health information
Health history
Medications
Surgery
17
11/2/2021
Nursing Assessment
Nutritional-metabolic
Activity-exercise
Sleep-rest
Cognitive-perceptual
Coping–stress tolerance
Physical assessment
General
Integumentary
Respiratory
Cardiovascular
Gastrointestinal
Neurologic
Laboratory findings
18
11/2/2021
Nursing Diagnoses
Anxiety
19
11/2/2021
at-risk patients
Respiratory therapy
Maintain PaO2 at 55 to 60 mm Hg or
more and SaO2 at 90% or more at the
lowest O2 concentration possible
20
11/2/2021
Respiratory therapy
Mobilization of secretions
Airway suctioning
Augmented Cough
Fig. 68-6
21
11/2/2021
Respiratory therapy
Noninvasive PPV
BiPAP
CPAP
22
11/2/2021
23
11/2/2021
Drug Therapy
Relief of bronchospasm
Bronchodilators
Corticosteroids
Drug Therapy
Treatment of pulmonary infections
IV antibiotics
Reduction of severe anxiety, pain, and agitation
Benzodiazepines
Narcotics
24
11/2/2021
Nutritional Therapy
Nutritional supplements
concentration
25
11/2/2021
Cardiovascular
Respiratory
26
11/2/2021
Nursing Diagnosis*
Impaired gas exchange related to alveolar
hypoventilation, intrapulmonary shunting,
V/Q mismatch, and diffusion
impairment as evidenced by hypoxemia
and/or hypercapnia
Patient Goal
Maintains adequate tissue oxygenation as indicated by
normal or baseline arterial blood gases
27
11/2/2021
28
11/2/2021
Acid-Base Management:
Respiratory Acidosis
Monitor for symptoms of respiratory failure
(e.g., low PaO2 and elevated PaCO2 levels
and respiratory muscle fatigue) to identify
need for ventilatory assistance.
29
11/2/2021
Dysrhythmia Management
• Monitor for and correct oxygen deficits,
acid-base imbalances, and electrolyte
imbalances that may precipitate
dysrhythmias.
• Apply ECG electrodes and connect to
cardiac monitor to identify dysrhythmias
30
11/2/2021
Nursing Diagnosis
Ineffective airway clearance related to excessive
secretions, decreased level of consciousness,
presence of an artificial airway, neuromuscular
dysfunction, and pain as evidenced by difficulty in
expectorating sputum, presence of rhonchi or
crackles, ineffective or absent cough
Airway Management
Encourage slow, deep breathing; turning;
and coughing to promote secretion removal.
Perform endotracheal or nasotracheal
31
11/2/2021
32
11/2/2021
Nursing Diagnosis
Ineffective breathing pattern relatedto neuromuscular
impairment of respirations, pain, anxiety, decreased level of
consciousness, respiratory muscle fatigue, and
bronchospasm as evidenced by respiratory rate <12 or >24
breaths/min, altered I : E ratio, irregular breathing pattern,
use of accessory muscles, paradoxic breathing, wheezing,
and apnea
Patient Goal
Demonstrates normal or baseline respiratory rate, rhythm,
and depth of respirations
Ventilation Assistance
Auscultate breath sounds, noting areas of
decreased or absent ventilation and
presence of adventitious sounds to assess for
compromised ability to sustain lung
ventilation.
33
11/2/2021
34
11/2/2021
Nursing Diagnosis
Imbalanced nutrition: less than body requirements related
to poor appetite, shortness of breath, presence of artificial
airway, decreased energy level, and increased caloric
requirements as evidenced by weight loss, weakness,
muscle wasting, dehydration, poor muscle tone, and poor
skin integrity
Patient Goals
1. Maintains intake adequate to meet body’s nutritional
needs
2. Experiences stable weight and muscle tone
35
11/2/2021
Nutrition Therapy
Determine in collaboration with the dietitian, the number of
calories and type of nutrients needed to meet nutrition
requirements.
Provide needed nourishment within limits of prescribed diet to
Oxygen Therapy
Monitor patient’s ability to tolerate removal of oxygen while
eating to prevent shortness of breath and blood oxygen
desaturation while eating.
36
11/2/2021
Nursing Diagnosis
Risk for imbalanced fluid volume related to sodium
and water retention
Patient Goals
1. Maintains stable body weight and balanced
intake and output
Fluid Management
• Monitor for indications of fluid
overload/retention (e.g., crackles, edema, neck
vein distention, ascites) to identify problem.
37
11/2/2021
Complications of ARF
Pulmonary Infections
Pulmonary embolism Nosocomial infection
barotrauma Pneumonia, UTI,
pulmonary fibrosis (ARDS) catheter related sepsis
Nosocomial pneumonia Renal
Cardiovascular ARF (hypoperfusion,
Hypotension, ↓COP
nephrotoxic drugs)
Poor prognosis
Arrhythmia
Nutritional
MI, pericarditis
Malnutrition, diarrhea
GIT
hypoglycemia,
Stress ulcer, ileus, diarrhea, electrolyte disturbances
hemorrhage
38
11/2/2021
Prognosis of ARF
Mortality rate for ARDS → 40%
Younger patient <60 has better survival rate
True or False
Dead space ventilation
decreases when blood flow is
reduced
٧٨
39
11/2/2021
True or False
Shunt occurs when areas of lung
are perfused but not ventilated
٧٩
True or False
In myasthenia gravis
mechanism of hypoxia may be
due to alveoli being perfused
but not ventilated
٨٠
40
11/2/2021
True or False
Arterial hypoxemia may be
caused by alveolar
hypoventilation alone
٨١
True or False
The distinction between ventilation/perfusion
mismatch and intrapulmonary shunting can be made
by measuring the response to the administration of
100% oxygen
٨٢
41
11/2/2021
True or False
There is a good relationship between dyspnea and
arterial hypoxemia but a poor relationship between
dyspnea and arterial carbon dioxide retention
٨٣
42